European Crohn´s and Colitis Organisation - ECCO - P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory
K-9 by ECCO
16 Graduate Jobs in Denmark with a deadline coming up – Graduateships